A large meta-analysis reviewed the benefits and risks associated with various treatments used for pediatric pain. One class of drugs stands out in particular.
Originally launched in 2006, the list aims to help pharmacies and other healthcare organizations by highlighting dangerous abbreviations, symbols and dose designations to avoid.
Pediatrician, pharmacologist–pharmacist group outlines factors to consider and introduces a new decision support tool to help care providers make informed decisions.
Abbey Ferguson with the Halifax Sexual Health Centre says PrEP—an antiviral medication that prevents HIV transmission—is so expensive that many people who would benefit from the drug are not able to take it.
